The HillIndependentCenter3 days ago
The FDA's data on mifepristone can't be trusted — here's whyThe article argues that the FDA's data on mifepristone cannot be trusted and emphasizes the need for the FDA to use robust, real-world data sources in its review process.
Bias read (Center): The article presents a general critique of the FDA's data without explicitly favoring one side politically. It calls for more robust data but does not frame the issue with clear ideological bias or loaded language.
